SOLE KWASU (S)-2-AMINO-3-{4-[4-(2,4-DIOKSO-TIAZOLIDYN-5-YLOMETYLO)- FENOKSY]-FENYLO}-PROPIONOWEGO I JEGO ESTRÓW METYLOWYCH JAKO INHIBITORY INTERLEUKINY DO LECZENIA OTYŁOŚCI LUB CUKRZYCY
Novel diphenyl ether derivatives are provided that exhibit activity useful for reducing glucose, cholesterol, and/or triglyceride levels in plasma, and for treatment of obesity, inflammation, immunological diseases, autoimmune diseases, diabetes and disorders associated with insulin resistance.